Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Impact Of Novel Agents To The Additional-Chromosomal Abnormalities In Patients With Multiple Myeloma

Kenshi Suzuki, MD, PhD, Yu Abe, Kanji Miyazaki, Rieko Sekine, MD, PhD, Nobuhiro Tsukada, MD, PhD, Yutaka Hattori, MD, PhD, Airi Hamano, Sumito Shingaki

Blood (2013) 122 (21): 3225.

https://doi.org/10.1182/blood.V122.21.3225.3225

Published: 2013

Journal Articles

Sustained Molecular Response with Maintenance Dose of Interferon Alfa After Imatinib Discontinuation in Patients with Chronic Myeloid Leukemia

Kensuke Usuki, MD, PhD, Nozomi Yusa, Akira Hangaishi, MD, PhD, Rieko Sekine, MD, PhD, Kenshi Suzuki, MD, PhD, Shinya Kimura, MD, PhD, Arinobu Tojo, MD, PhD.

Blood (2012) 120 (21): 1684.

https://doi.org/10.1182/blood.V120.21.1684.1684

Published: 2012

Journal Articles

Discovery Research On the Effects of Continuous Administration of Bortezomib Maintenance Therapy to Treat Patients with Relapsed and Refractory Multiple Myeloma - Analysis of Background Factors That Affect the Continuity of Therapy-

Kenshi Suzuki, MD, PhD, Nobuhiro Tsukada, MD, PhD, Yu Abe, MD, Rieko Sekine, MD, PhD, Yasunori Nakagawa, MD, PhD

Blood (2012) 120 (21): 1866.

https://doi.org/10.1182/blood.V120.21.1866.1866

Published: 2012

Journal Articles

Development of a Unique In Vitro and In Vivo Model System of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph-ALL) with Emphasis on Cell to Cell Interaction.

Arinobu Tojo, MD, PhD, Kiyoko Izawa, PhD, Rieko Sekine, MD, Tokiko Nagamura-Inoue, MD,PhD, Seiichiro Kobayashi, MD,PhD

Blood (2006) 108 (11): 1845.

https://doi.org/10.1182/blood.V108.11.1845.1845

Published: 2006

Journal Articles

Constitutive Expression of Pax5 in Cord Blood Progenitor Cells Rather Inhibits B Lymphopoiesis as Well as Myelopoiesis through the Exon 9-Dependent and Independent Mechanism.

Rieko Sekine, Toshio Kitamura, Takashi Tsuji, Arinobu Tojo

Blood (2005) 106 (11): 2718.

https://doi.org/10.1182/blood.V106.11.2718.2718

Published: 2005

Journal Articles

Leptomycin B Overcomes Imatinib Resistance Mediated by Stromal Cells and Mutant BCR-ABL in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Cells.

Arinobu Tojo, MD, PhD, Kiyoko Izawa, PhD, Rieko Sekine, Tokiko Nagamura, MD, PhD, Minoru Yoshida, PhD, Takashi Tsuji, PhD

Blood (2004) 104 (11): 2089.

https://doi.org/10.1182/blood.V104.11.2089.2089

Published: 2004

NARROW

Impact Of Novel Agents To The Additional-Chromosomal Abnormalities In Patients With Multiple Myeloma

Sustained Molecular Response with Maintenance Dose of Interferon Alfa After Imatinib Discontinuation in Patients with Chronic Myeloid Leukemia

Discovery Research On the Effects of Continuous Administration of Bortezomib Maintenance Therapy to Treat Patients with Relapsed and Refractory Multiple Myeloma - Analysis of Background Factors That Affect the Continuity of Therapy-

Development of a Unique In Vitro and In Vivo Model System of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph-ALL) with Emphasis on Cell to Cell Interaction.

Constitutive Expression of Pax5 in Cord Blood Progenitor Cells Rather Inhibits B Lymphopoiesis as Well as Myelopoiesis through the Exon 9-Dependent and Independent Mechanism.

Leptomycin B Overcomes Imatinib Resistance Mediated by Stromal Cells and Mutant BCR-ABL in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Cells.

Email alerts

ASH Publications

American Society of Hematology

Impact Of Novel Agents To The Additional-Chromosomal Abnormalities In Patients With Multiple Myeloma

Sustained Molecular Response with Maintenance Dose of Interferon Alfa After Imatinib Discontinuation in Patients with Chronic Myeloid Leukemia

Discovery Research On the Effects of Continuous Administration of Bortezomib Maintenance Therapy to Treat Patients with Relapsed and Refractory Multiple Myeloma - Analysis of Background Factors That Affect the Continuity of Therapy-

Development of a Unique In Vitro and In Vivo Model System of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph-ALL) with Emphasis on Cell to Cell Interaction.

Constitutive Expression of Pax5 in Cord Blood Progenitor Cells Rather Inhibits B Lymphopoiesis as Well as Myelopoiesis through the Exon 9-Dependent and Independent Mechanism.

Leptomycin B Overcomes Imatinib Resistance Mediated by Stromal Cells and Mutant BCR-ABL in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Cells.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only